Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Munich

World Forum on Biotechnology and Bioscience

The Forum is designed as a premier global platform dedicated to presenting and discussing the latest research and scientific advancements in Biotechnology and Bioscience. This [...]

Go to Top